215 related articles for article (PubMed ID: 11968010)
1. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy.
Alvarez K; Fadic R; Brandan E
J Cell Biochem; 2002; 85(4):703-13. PubMed ID: 11968010
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
Winkler S; Stahl RC; Carey DJ; Bansal R
J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
[TBL] [Abstract][Full Text] [Related]
4. Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localization.
Hjelm Cluff A; Malmström A; Tingåker B; David G; Ekman-Ordeberg G
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):217-24. PubMed ID: 15715528
[TBL] [Abstract][Full Text] [Related]
5. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
7. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
Larraín J; Alvarez J; Hassell JR; Brandan E
Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
[TBL] [Abstract][Full Text] [Related]
8. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
Asundi VK; Keister BF; Stahl RC; Carey DJ
Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and processing of glypican during differentiation of skeletal muscle cells.
Brandan E; Carey DJ; Larraín J; Melo F; Campos A
Eur J Cell Biol; 1996 Oct; 71(2):170-6. PubMed ID: 8905294
[TBL] [Abstract][Full Text] [Related]
11. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
13. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
14. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
[TBL] [Abstract][Full Text] [Related]
15. Shedding light on the distinct functions of proteoglycans.
Selleck SB
Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
[TBL] [Abstract][Full Text] [Related]
16. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells.
Asundi VK; Erdman R; Stahl RC; Carey DJ
J Neurosci Res; 2003 Sep; 73(5):593-602. PubMed ID: 12929127
[TBL] [Abstract][Full Text] [Related]
18. Perlecan and syndecan-4 in uterine tissues during the early pregnancy in mice.
San Martin S; Soto-Suazo M; Zorn TM
Am J Reprod Immunol; 2004 Jul; 52(1):53-9. PubMed ID: 15214943
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
